AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

15 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024

02 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio

08 янв 2024 07:00:01 Источник Nasdaq GlobeNewswire

Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia

03 янв 2024 06:30:00 Источник Nasdaq GlobeNewswire

Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

02 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition

09 дек 2023 19:00:00 Источник Nasdaq GlobeNewswire

Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes

20 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorders at 65th ASH Annual Meeting and Exposition

02 ноя 2023 09:05:00 Источник Nasdaq GlobeNewswire

Agios Reports Business Highlights and Third Quarter 2023 Financial Results

02 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023

19 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023

29 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios Reports Business Highlights and Second Quarter 2023 Financial Results

03 авг 2023 06:35:00 Источник Nasdaq GlobeNewswire

Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera

03 авг 2023 06:30:00 Источник Nasdaq GlobeNewswire

Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023

13 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response

26 июн 2023 06:30:00 Источник Nasdaq GlobeNewswire

Agios to Present at the Goldman Sachs Global Healthcare Conference on June 15, 2023

05 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios Appoints Catherine Owen to Board of Directors

25 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

Agios to Present Clinical and Translational Data at European Hematology Association Annual Congress

11 май 2023 10:00:00 Источник Nasdaq GlobeNewswire

Agios Reports Business Highlights and First Quarter 2023 Financial Results

04 май 2023 07:00:02 Источник Nasdaq GlobeNewswire

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023

25 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire